Deal History
About us
The Company
Team
Offices
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Research
Equity Research
Macro and Markets
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
INT
DA
DE
FR
SV
US
Main menu button
Team
Deals
Contact
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lokotech
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
21 Feb 2024
Carlsquare weekly market letter: All eyes on Nvidia!
Equity Research
Carlsquare
14 Feb 2024
Carlsquare weekly market letter: Is a change of the wind in the making?
Equity Research
Carlsquare
07 Feb 2024
Carlsquare weekly market letter: Getting closer to the magic line of 5000
Equity Research
Carlsquare
31 Jan 2024
Carlsquare weekly market letter: Follow the wind!
Equity Research
Carlsquare
24 Jan 2024
Carlsquare weekly market letter: In China, something big is happening
Equity Research
Carlsquare
17 Jan 2024
Carlsquare weekly market letter: Can 2024 be a positive year despite, or perhaps because of, the US presidential election?
Equity Research
Carlsquare
20 Dec 2023
Carlsquare weekly market letter: Enjoy the ride- January can be the month for an hangover
Equity Research
Carlsquare
13 Dec 2023
Carlsquare weekly market letter: Busy week. Fed could surprise the market
Equity Research
Carlsquare
29 Nov 2023
Carlsquare weekly market letter: Time for China and gold?
Equity Research
Carlsquare
08 Nov 2023
Carlsquare weekly market letter: Yellen triggers a great rebound. A new politics in the coming?
Equity Research
Carlsquare
01 Nov 2023
Carlsquare weekly market letter: Will the pain trade continue?
Equity Research
Carlsquare
18 Oct 2023
Carlsquare weekly market letter: Something has to give
Equity Research
Carlsquare
11 Oct 2023
Carlsquare weekly market letter: Turnaround could last until year-end
Equity Research
Carlsquare
27 Sep 2023
Carlsquare weekly market letter: Oil gives new energy to inflation, not a good sign
Equity Research
Carlsquare
20 Sep 2023
Carlsquare weekly market letter: Focus on debt again...
Equity Research
Carlsquare
13 Sep 2023
Carlsquare weekly market letter: Is the IPO market opening up?
Equity Research
Carlsquare
06 Sep 2023
Carlsquare weekly market letter: A second energy crisis on the horizon?
Equity Research
Carlsquare
30 Aug 2023
Carlsquare weekly market letter: September is Christmas for traders
Equity Research
Carlsquare
23 Aug 2023
Carlsquare weekly market letter: China and the US are dithering. The boat is rocking
Equity Research
Carlsquare
16 Aug 2023
Carlsquare weekly market letter: The market breaks downwards
Equity Research
Carlsquare
1
2
3
4
5